Jiangsu Aosaikang Pharmaceutical Co., Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   2 trials marked Unknown by the registry's verification sweep

   1. Minor

      ASK120067 Versus Gefitinib as First-line Treatment for EGFRm…ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC

      Registry marked status Unknown (sponsor has not verified the record since Jun 2024); last known: Active, Not Recruiting

      Jiangsu Aosaikang Pharmaceutical Co., Ltd.·Phase 3· NCT04143607· Registry history of NCT04143607 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   2. Minor

      ASKC200 · ASKC200 in Osteoarthritic Knee Pain

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting

      Jiangsu Aosaikang Pharmaceutical Co., Ltd.·Phase 1· NCT06614608· Registry history of NCT06614608 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   Registry verification sweep

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.